View the full list of references supporting this article in European Pharmaceutical Review, Issue 02 2026.

References

1. A. Bourderi-Cambon, K. Fadhlaoui, et al., Lipid Excipients As Key Modulators Of The Apparent Intestinal Permeability In Lipid-Based Formulations: Insights From Caco-2 And Caco-2/HT29-MTX Models, European Journal of Pharmaceutics and Biopharmaceutics, 2026;223.

2. S. Yan, Y. Cheng, et al., Lipid-Based Formulations: A Promising Approach For Poorly Soluble Drug Delivery Via The Intestinal Lymphatic System, Journal of Drug Delivery Science and Technology, 2023; 87.

3. E. Gattefossé, D. Schneider et al., Ticagrelor Amorphous Solid Dispersion Tablets: Formulation with Gelucire® 48/16. Poster presented at CRS 2025. [Internet] Gattefossé.

4. K. Deshmukh, V. N. Gadlawar et al., Platform Technology For Introducing Liquid Solubilizers In Tablet Formulations, Poster presented at AAPS 2024. [Internet] Gattefossé.